This site is intended for healthcare professionals only
LoginRegister
Drug, Vaccine Lab Tests May Cost Up to Rs 45,000 with 5% Annual HikeRajasthan Drug Official Under Probe for Misreporting Spurious Medicines
Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial ProtocolIntas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol
AbbVie Loses India Patent Bid for Cancer Drug Venetoclax, Generics Set to Enter MarketAbbVie to Launch Ovarian Cancer Drug ELAHERE in UK at US Price Levels
Kala Bio Halts Eye Drug Development After Phase 2b Trial FailureKala Bio Halts Eye Drug Development After Phase 2b Trial Failure
Novartis concludes acquisition of Tourmaline BioNovartis commences tender offer to buy Tourmaline Bio
AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia TreatmentAstraZeneca to harmonise its listing structure across LSE, STO and NYSE
Johnson and Johnson Gets CDSCO Panel Nod for Talqetamab in Relapsed Multiple Myeloma, Phase IV Trial MandatedJnJ Tremfya gets USFDA nod for pediatric plaque psoriasis, active psoriatic arthritis
Amgen announces USD 650 million expansion of US manufacturingAmgen announces USD 650 million expansion of US manufacturing network
ZydusZydus Lifesciences Slapped Rs 3.35 Crore Tax Demand Over CENVAT Credit
Surat Businessman Arrested in Rs 8.5 Crore Pharma Fraud, Probe on AccomplicesSurat Businessman Arrested in Rs 8.5 Crore Pharma Fraud, Probe on Accomplices
Gujarat HC Halts DGGI Action on Rs 56.33 Cr GST Demand Against Zydus UnitRelief Sought for Small Retailers as GST 2.0 Sparks Losses in Pharma Trade
CDSCO Panel Seeks Revised Phase IV Trial Protocol for MSN Labs Nelarabine InjectionMSN Lab gets CDSCO panel nod for Phase IV CT of Tofacitinib Oral Solution
X